Lucira Health, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Lucira Health, Inc. | LHDX - NASDAQ |
$15.00-$17.00 | $17.00 | $22.10 | 9 million | 2/5/2021 |
| BofA Securities, William Blair | ||||||
Co-Manager(s): LifeSci Capital
| ||||||
| Health Care | ||||||
Filing(s): Filed 2021-01-15 Terms Added 2021-02-01 | ||||||
Lucira Health, Inc. Quote & Chart - Click for current quote - LHDX
IPO Boutique aggregates information on public companies and private companies, such as "LHDX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Lucira Health, Inc. (adapted from Lucira Health, Inc. prospectus):
They are a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "LHDX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.